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Meniscal pathology is common and the prevalence 
is associated with increasing age and the develop-
ment of osteoarthritis (OA).1 Meniscal lesions are 
associated with a wide variety of symptoms and 
signs and may, for example, be asymptomatic or 
an incidental finding in patients with knee pain 
due to OA.1-4 When a meniscal lesion is thought 
to be the cause of symptoms, surgery to excise or 
repair the unstable tissue may be recommended.
Recently, a series of clinical trials has been 
published evaluating the effectiveness of excis-
ing a meniscal tear by arthroscopic partial menis-
cectomy.5-10 Although these studies have made 
an important contribution to the literature, the 
generalizability of the findings has been contro-
versial due to the broad and inconsistently defined 
inclusion criteria applied to such a heterogeneous 
group of patients.11-17 Given the persistent areas 
of uncertainty, and concerns about rare adverse 
events that may be associated with arthroscopic 
partial meniscectomy, there is a clear need for 
agreement on how to investigate, describe, strat-
ify, and manage patients with meniscal lesions.
The aim of this study was to develop a national 
surgical consensus on how to describe and man-
age patients with meniscal pathology consistently, 
including agreement on the combination of clin-
ical features that determine which patients are 
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Aims
The aim of the British Association for Surgery of the Knee (BASK) Meniscal Consensus 
Project was to develop an evidence-based treatment guideline for patients with meniscal 
lesions of the knee.
Materials and Methods
A formal consensus process was undertaken applying nominal group, Delphi, and 
appropriateness methods. Consensus was first reached on the terminology relating to 
the definition, investigation, and classification of meniscal lesions. A series of simulated 
clinical scenarios was then created and the appropriateness of arthroscopic meniscal 
surgery or nonoperative treatment in each scenario was rated by the group. The process 
was informed throughout by the latest published, and previously unpublished, clinical and 
epidemiological evidence. Scenarios were then grouped together based upon the similarity 
of clinical features and ratings to form the guideline for treatment. Feedback on the draft 
guideline was sought from the entire membership of BASK before final revisions and 
approval by the consensus group.
Results
A total of 45 simulated clinical scenarios were refined to five common clinical presentations 
and six corresponding treatment recommendations. The final guideline stratifies patients 
based upon a new, standardized classification of symptoms, signs, radiological findings, 
duration of symptoms, and previous treatment.
Conclusion
The 2018 BASK Arthroscopic Meniscal Surgery Treatment Guidance will facilitate the 
consistent identification and treatment of patients with meniscal lesions. It is hoped 
that this guidance will be adopted nationally by surgeons and help inform healthcare 
commissioning guidance. Validation in clinical practice is now required and several 
areas of uncertainty in relation to treatment should be a priority for future high-quality 
prospective studies.
Cite this article: Bone Joint J 2019;101-B:652–659.
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Fig. 1
Flowchart of the consensus process. BASK, the British Association for Surgery of the Knee; OA, 
osteoarthritis; RAM, RAND/UCLA Appropriateness Method.
candidates for surgical treatment and which are candidates for 
non-surgical treatment options.
Materials and Methods
In November 2016, 25 experts were invited to participate in the 
British Association for Surgery of the Knee (BASK) Meniscal 
Working Group by its research committee and study steering 
committee. These experts were surgeons and were selected 
due to a combination of: 1) their interests and publication his-
tory; 2) their clinical specialism; and 3) peer-recognition and 
recommendations. In addition to the steering committee, 21 
of the invited surgeons agreed to participate (as listed in the 
acknowledgements). A summary of the consensus process is 
shown in Figure 1.
Terminology exercise. The scope of the process and the clas-
sification and terminology relevant to patients with a meniscal 
lesion was defined by the Working Group in the initial phase, 
and this has recently been published.18 Prior to the first meeting, 
the literature on arthroscopic meniscectomy was provided to 
the group electronically, and the meeting was conducted using 
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nominal group techniques.19 Iterative questionnaires were then 
circulated to the group, following a Delphi type methodology,18 
and statements were agreed. The definitions, approach to imag-
ing investigations, and classification of meniscal lesions and 
OA, which were agreed in this phase, are summarized on the 
second page of the full guideline document (Supplementary 
Fig. ab).
Surgical ‘appropriateness’ exercise. Surgical appropriateness 
rating exercises are well established and have been used pre-
viously to deliver recommendations for a wide range of med-
ical and surgical treatments.20-24 In this study, we applied the 
validated RAND/UCLA Appropriateness Method (RAM).25 
RAM was first developed in the 1980s and designed for the 
estimation of the over- or under-use of medical or surgical 
interventions by applying a consensus-based technique.25 RAM 
provides the opportunity to use controlled interaction between 
experts in order to derive knowledge and recommendations for 
treatment. The process is informed by the existing evidence, 
including clinical effectiveness data, but not reliant on such data 
where none is currently available. The anonymous rating pro-
cess aims to limit the impact from experts otherwise showing 
“unwillingness to abandon publicly held beliefs” or the pressure 
to conform.26
Following the conclusion of the Delphi rounds, population 
and patient selection factors were defined and agreed, as pub-
lished.18 Based on these findings, mutually exclusive clinical 
scenarios were prepared from combinations of factors to make 
up a range of simulated ‘patients’ for the panel to evaluate. The 
scenarios were created from a combination of: 1) severity of 
meniscal symptoms and signs (locked knee, meniscal predom-
inant, possibly meniscal, arthritic, mixed arthritic, and menis-
cal); 2) severity of OA (early or no OA, mild or moderate OA, 
advanced OA); and 3) meniscal findings on MRI (target, pos-
sible target, no target).18 A total of 45 scenarios were voted on 
by members of the group during the RAM exercise, the first 
round of which was conducted anonymously between meetings 
(Fig. 1).
An introduction and standardized history of a patient was pre-
sented for the purposes of the voting and members of the group 
were then asked: “Do you think meniscal surgery is appropri-
ate in this patient? (To what extent do you believe arthroscopic 
meniscal surgery would benefit symptoms and quality of life 
AND outweigh the risks of surgery / benefit of an alternative, 
more appropriate, treatment option.)” A rating for each clini-
cal scenario was requested on a scale from 1 (inappropriate) 
to 9 (appropriate). In accordance with published standards, the 
degree of agreement between participants was measured by 
evaluating the median and spread of rating.25,27,28 A median rat-
ing ≥ 7 without disagreement was defined a priori as appropri-
ate and a median rating ≤ 3 without disagreement was defined 
as inappropriate. Disagreement was defined as more than one-
third of votes ≤ 3 with a median ≥ 7, or more than one-third 
of votes ≥ 7 with a median ≤ 3. Uncertainty was recorded for 
median scores between 4 and 6.
Participants were also invited to make recommendations 
for treatment, in a modified ‘necessity’ rating exercise.25 For 
a procedure such as arthroscopic meniscectomy, the risk of 
the procedure may be considered so low that it could be rated 
‘appropriate’ even when the clinical value is uncertain, and 
this exercise aimed to overcome this limitation.25 Four options 
were provided: 1) “urgent”  arthroscopic meniscal surgery, 
where the expected benefit is not small and it would be con-
sidered ‘improper’ not to offer the treatment; 2) “routine” 
arthroscopic meniscal surgery (i.e. appropriate but not urgent); 
3) “non- surgical treatment and re-assess”, where the benefit 
from meniscal surgery is uncertain; and 4) “no arthroscopy”, 
where no benefit is anticipated, or harms exceed anticipated 
benefits. Agreement on this recommendation item was defined 
at > 50% (majority threshold).
Following the first round of RAM voting, the group met to 
discuss the results (Fig. 1). At this meeting, each participant was 
provided with a document showing their own rating and the 
summary ratings from the other participants.25 The results were 
discussed, focusing on areas of disagreement or uncertainty. 
Scenarios with disagreement were clarified and all relevant 
evidence was discussed in this context. Each participant then 
re-rated every scenario, so that each participant had rated every 
scenario twice. The intention of two rounds of voting is to dis-
tinguish true clinical disagreement (‘real’ disagreement) from 
fatigue or misunderstanding (‘artefactual’ disagreement).25
On completion of the RAM exercise, 11 scenarios (24%) 
were rated appropriate for arthroscopic meniscal surgery, 24 
scenarios (53%) were rated inappropriate, and ten scenarios 
(22%) were uncertain. Treatment recommendations exceeded 
the 50% majority classification threshold in 43 scenarios (96%). 
The remaining two were discussed by the steering group and 
recommendations were made based upon the spread of votes 
and other ratings. Of the 11 appropriate cases, five (45%) were 
rated eligible for urgent surgery and six (55%) for routine sur-
gery. Of the 24 inappropriate cases, 17 (71%) were rated for 
no arthroscopy and seven (29%) were rated for re-assessment 
after further nonoperative treatment. All ten uncertain cases 
(100%) were rated for re-assessment after further nonoperative 
treatment.
Preparing the treatment guideline. The output from the 
RAM exercise was used to prepare a management guideline 
for patients with meniscal lesions confirmed on imaging. The 
RAM scenarios were grouped by the steering committee based 
on the clinical features and ratings to create a smaller number 
of representative presentations and treatment recommenda-
tions. These were used as the basis of a draft flowchart-style 
guideline for treatment, which was circulated to the group 
for electronic feedback. Based on this feedback, amendments 
were made prior to discussion again at a meeting in March 
2018, when the guideline was discussed in detail, taking into 
account an update on the latest evidence including a previ-
ously unpublished systematic review of evidence from a clin-
ical trial stratified by the important patient factors, and a new 
analysis of the risks of arthroscopic surgery of the knee using 
national epidemiological data.29,30 Changes agreed at this meet-
ing were made to the guideline and this was then presented at 
the annual BASK congress in March 2018 in order to introduce 
the guideline with a request for feedback from the membership 
of BASK.
Peer-review, feedback, and final approval. Following produc-
tion of the draft guideline, it was subjected to peer review. First, 
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the guideline, accompanying definitions, and case management 
examples were circulated electronically to the membership of 
BASK for feedback. Of the 195 full active members of BASK 
with valid consent and contact details to receive surveys, 117 
(60%) completed the survey in full. Of these, 87 respondents 
(74%) agreed with the treatment guideline without changes, a 
further 28 (24%) agreed and thought minor changes should be 
made, and two disagreed and thought major changes should be 
made (2%). Overall, 113 respondents (97%) agreed to practice 
according to this guideline with no further changes. Specific 
comments were received from 34 respondents (12 from the 
no changes group, 21 from the minor changes group, and one 
from the major changes group). Of the comments, 13 confirmed 
support, leaving 21 responses with suggestions for changes. 
The only major comment was to highlight the importance of 
the discretion of the surgeon and the preferred treatment of the 
patient, and one minor comment also made this point. Of the 
other minor comments, nine suggested small amendments to 
the definitions and descriptions, two related to introducing age 
cut-offs, four related to the importance of highlighting rare but 
important cases where meniscal surgery may be appropriate 
despite advanced OA, and four related to improving the clarity 
or wording of the guideline itself.
All comments and the ratings were reviewed by the steering 
committee and the Working Group and, based on these, further 
minor changes were made. The final guideline was reviewed 
and approved by the Working Group in September 2018.
Results
Terminology and guideline eligibility. The agreed terminol-
ogy developed for the purposes of developing the guideline has 
been published and is included on the second page of the doc-
ument (Supplementary Fig. ab).18 A meniscal ‘tear’ is a defect 
or split in the meniscocapsular complex, which can occur in 
a degenerative or non-degenerative meniscus. A degenerative 
meniscus was defined as one with progressive degradation of 
meniscal tissue as may be revealed by intra-meniscal high sig-
nal on MRI. It was agreed that for the guidance from the flow-
chart to be applicable, MRI confirmation of a lesion would be 
necessary.
The classification of meniscal lesions was based on appear-
ances on MRI into target, possible target, or no target.18 The 
target group represented ‘treatable’ lesions for which the group 
agreed that meniscal surgery may be indicated based on appear-
ance. Some caution is required, however, in the interpretation 
of a static knee MRI, given the potential for the displacement 
Fig. 2
The British Association for Surgery of the Knee (BASK) Meniscal Tear Management Guideline flowchart.
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of a tear on movement. Three categories of severity of OA were 
defined; however, the clinical ratings exercise and subsequent 
discussions indicated that only advanced OA was considered a 
major contraindication to arthroscopic meniscal surgery. There-
fore, the recommendations for treatment are for all patients with 
early, mild, or moderate OA (Fig. 2; Supplementary Fig. ab) 
are the same – that is, they are based on the pattern of the 
meniscal lesion, the symptoms and signs, duration of symp-
toms, and previous treatment. Patients with advanced OA were 
placed in a separate category (see the ‘Treatment recommenda-
tions’ section below). It was agreed that no age specifications 
would be included but the guideline was not designed for use in 
children.
Common clinical presentations. Based on summary responses 
(treatment appropriateness; treatment recommendations), an 
initial total of 45 clinical scenarios were rationalized to just five 
common and discriminative clinical presentations. It was recog-
nized that clinician judgement is still required, however, espe-
cially where the presentations of the patients do not fit clearly 
into one of these categories. The five accepted presentations 
were: 1) locked knee; 2) acute injury with a target meniscal 
lesion; 3) target meniscal lesion with corresponding symptoms 
and signs; 4) possible target meniscal lesion with corresponding 
symptoms and signs; and 5) advanced structural OA.
Treatment recommendations. The group agreed to four pos-
sible treatment recommendations for meniscal lesions: urgent 
arthroscopic meniscal surgery; consider arthroscopic menis-
cal repair; consider non-urgent arthroscopic partial meniscec-
tomy; and optimized non-surgical treatment and re-assessment. 
Patients with advanced OA were included in a fifth category for 
“no arthroscopic meniscal surgery” and may need assessment 
of other pathology that might require alternative treatment, 
such as osteotomy or arthroplasty. The recommendation for 
each presentation is shown on the first page of the document 
(Fig. 2).
Urgent arthroscopic surgery was recommended for patients 
with a locked knee. In most cases, these patients will have a 
confirmed diagnosis of a displaced meniscal tear from MRI. 
However, it was accepted by the group that for patients present-
ing with a locked knee, clinicians may apply their judgement on 
the need for preoperative MRI imaging.
Meniscal repair was recommended to preserve the meniscus 
when a reparable target lesion is identified following an acute 
injury. A decision to proceed in these cases requires clinical 
judgement about the potential for healing based on patient, ana-
tomical, biomechanical, and biological factors. No recommen-
dation on the urgency of intervention was included, as it was 
agreed that this decision should be made by the clinician on a 
case-by-case basis, in careful consultation with the patient. Fur-
ther work to refine guidance on this decision about treatment is 
planned.
In most patients, according to the guideline, at least three 
months should have elapsed from the onset of symptoms before 
arthroscopic meniscal surgery is considered. Only patients with 
“meniscal” or “possibly meniscal” symptoms and signs were 
considered eligible for arthroscopic meniscal surgery (Fig. 2; 
Supplementary Fig. ab). In patients with “meniscal” symp-
toms and signs and a “meniscal target”, routine arthroscopic 
meniscal surgery may be considered three months from the 
onset of symptoms. In some patients, earlier surgery may be 
appropriate and it was advised that a second opinion from an 
appropriately experienced colleague be sought and documented 
before proceeding with arthroscopic meniscal surgery in these 
cases. In patients with “possibly meniscal” symptoms and signs 
or a “possible meniscal target”, further optimized non-surgical 
treatment for an additional three months was recommended 
(on first assessment in secondary care). Optimized non-surgi-
cal treatment was agreed to be patient- and condition-specific; 
however, the group suggested that this may include providing 
patient education, structured physiotherapy, and, in some cases, 
an intra-articular steroid injection (Fig. 2).
Arthroscopic meniscal surgery was judged to be inappropri-
ate in nearly all patients with advanced OA or with arthritic 
symptoms and signs only (Fig. 2; Supplementary Fig. ab). It 
was acknowledged, however, that there are some uncommon 
special circumstances when it was advised that a second opin-
ion from an appropriately experienced colleague be sought 
and documented before proceeding with arthroscopic meniscal 
surgery.
Finally, there was universal agreement that the patient’s 
preferred form of treatment must always be considered. The 
guideline document should support, not substitute for, shared 
decision making.
Discussion
In this study, we have delivered a guideline to the management 
of a meniscal tear using validated consensus methodology 
in collaboration with BASK. For patients with advanced OA 
on imaging or arthritic symptoms only, arthroscopic meniscal 
surgery is not recommended. In patients with a locked knee, 
urgent arthroscopic surgery is recommended. For patients sus-
taining an acute injury to the knee that results in a target menis-
cal lesion, arthroscopic meniscal repair should be considered 
to preserve meniscal tissue if possible. For all other patients, a 
minimum period of three months of non-surgical therapy is rec-
ommended before considering arthroscopic meniscal surgery. 
An additional three months of non-surgical therapy, including 
physiotherapy, is recommended for all patients without a clear 
target meniscal lesion with correlating meniscal symptoms on 
first assessment in secondary care.
Reviewing the published evidence throughout the develop-
ment of this guideline, several areas of uncertainty were high-
lighted. First, as previously identified by other groups, no trial 
has been performed in patients with a meniscal lesion and a 
locked knee.31,32 A locked knee is functionally disabling and, 
given the high ratings for the appropriateness of surgical treat-
ment for this indication, recruitment to such a trial may not be 
feasible due to strong patient preferences and a lack of equipoise. 
For patients with advanced OA, evidence from randomized 
controlled trials indicates that arthroscopy is unlikely to be 
effective.33 For patients eligible for meniscal repair to preserve 
meniscal tissue after an acute injury, there were high ratings for 
the appropriateness of surgery, but no relevant high-level evi-
dence was identified and this should be a priority area for fur-
ther research.34-38 Although a number of clinical trials have been 
undertaken to evaluate the effectiveness of arthroscopic partial 
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meniscectomy, the interpretation of these is challenging due to 
broad inclusion criteria: knee pain, any meniscal lesion, often 
with OA, no previous nonoperative treatment, and high rates 
of crossover in patients recruited to a non-arthroscopic partial 
meniscectomy treatment arm.17,30 The consensus view, based on 
this evidence, was that most patients should receive a minimum 
of three months of nonoperative treatment before undergoing 
surgery. First-line nonoperative treatment was recommended 
for all patients with only a possible target meniscal lesion or 
possible meniscal symptoms. These recommendations reflect 
recent evidence from clinical trials, as the patients recruited to 
these trials had generally non-specific clinical and radiological 
findings.30 In these trials, most patients improved when rand-
omized to undergo structured physiotherapy; however, up to 
30% ‘crossed over’ to undergo arthroscopic partial meniscec-
tomy due to a lack of improvement.30 These ‘crossover’ patients 
reportedly improved after surgery, and this is the basis of the 
recommendation for first-line nonoperative treatment with sur-
gery being reserved for non-responders.
Regarding the harms of arthroscopic meniscal surgery, a new 
analysis of national epidemiology data from patients who had 
undergone arthroscopic partial meniscectomy informed the 
decisions of the group.29 The work established that while this 
surgery is low-risk and not associated with an increased risk of 
myocardial infarction, cerebrovascular accident, or death when 
compared with the rates for the general population, infection 
and pulmonary embolism, although rare, may be provoked 
by arthroscopy.29 The recommendations were prepared in the 
context of this new evidence, with the evidence for benefits 
weighed against the anticipated risk of harms.29,30
In England, although there has been a recent decline in the 
rate of arthroscopy of the knee being performed, there remains 
considerable age-group and regional variation in practice and 
the ‘appropriate’ rate of surgery remains unknown.39 The report-
ing of this guideline aims to facilitate a standardized approach 
to treatment to minimize variation in practice and, once applied, 
it may also allow for the estimation of an ‘appropriate’ rate of 
surgery.
The aim was to distil the current evidence and expert opinion, 
where there was a lack of evidence or uncertainty. The develop-
ment of the guideline was informed throughout by high-quality 
published and previously unpublished evidence about the ben-
efits and harms associated with arthroscopic meniscal surgery. 
The previously unpublished evidence included a systematic 
review and analysis of 20 years of national epidemiological 
data performed for this purpose.29,30 Any rigorously under-
taken consensus process aims to deliver the best possible out-
put from the evidence available at the time, but this does not 
guarantee that the output is ‘correct’ or indeed that there is a 
‘correct’ output.40,41 A period of validation is required followed 
by modification if indicated to be required in response to new 
evidence.
The composition of the consensus group is crucial to ensure 
that the output is valid and of value.19 The aim of this study was 
to produce a ‘best-practice’ guideline for use by surgeons and 
patients in secondary (hospital) care, but it is hoped that it will 
also inform a coordinated treatment approach along with pri-
mary (general practice) care practitioners and physiotherapists. 
For this purpose, the BASK research committee decided that 
the output from a group of recognized expert surgeons would 
be most likely to become the accepted standard of practice for 
surgeons in secondary care. Indeed, the high level of agreement 
within the group and the feedback from the BASK membership 
support this reasoning. One potential criticism of a consensus 
group composed of experts, however, is that high-volume sur-
geons are more likely to recommend surgery due to their belief 
in an intervention.42 Such a lack of ‘equipoise’ has been termed 
the ‘enthusiasm hypothesis’.43,44 Nevertheless, all members of 
the group had reported a change in their practice directly in 
response to the publication of evidence favouring the effective-
ness of physiotherapy in many patients with meniscal lesions. 
Other groups, such as general practitioners, rheumatologists, 
and physiotherapists may interpret the evidence differently for 
their own areas of practice, but this study was not designed to 
change the practice of these groups, and further work to deliver 
collaborative recommendations from all involved groups would 
be beneficial. There was a clearly identified need for further 
clinical evidence in several areas; for example, no previous clin-
ical trial has limited recruitment to patients eligible for meniscal 
surgery according to these new standards, and this should be a 
priority for further research.17,30
Although guidelines have been published by other groups, 
these have presented conflicting recommendations, suffered 
from a number of limitations, and have not yet been accepted 
into practice.31,32,42,45,46 In contrast, on peer-review, 97% of spe-
cialist knee surgeons (113/117) agreed to practise according 
to the guideline presented here and, with the support of the 
national knee society, BASK, and the NHS Getting It Right 
First Time (GIRFT) programme in the United Kingdom,47 
adoption into routine clinical practice and secondary care com-
missioning is anticipated. Further development is also planned 
to prepare more general guidance, involving other stakeholder 
groups including general practitioners, health commissioners, 
rheumatologists, patients, and physiotherapists.
In conclusion, the management guideline reported here rep-
resents current expert surgical opinion regarding the appropri-
ate management of patients with a meniscal lesion. It was 
delivered using a series of consensus exercises and has been 
endorsed in its current form by the national knee society, BASK, 
and by the NHS GIRFT programme. The aim of the guideline is 
to standardize treatment and facilitate best-practice based on 
current evidence. Validation in clinical practice is now required 
and, where uncertainty was highlighted, there is an urgent need 
for more evidence.
Take home message
- In the context of shared decision making, this guidance 
aims to protect patients from unnecessary surgery while en-
suring appropriate access to arthroscopic meniscal surgery 
where benefit is anticipated.
- Arthroscopic meniscal surgery should not be performed in patients with 
advanced osteoarthritis except in rare special cases.
- Most patients presenting with a target meniscal lesion and symptoms 
should first undergo at least three months of nonoperative treatment. For 
patients not responding to this nonoperative treatment, meniscal surgery 
may be beneficial and should be considered.
- Urgent surgery may be indicated for patients with a locked knee. Menis-
cal repair should be considered in patients with a reparable meniscal tear 
following acute injury.
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